FundLens
73
Pharma & HealthcareBuy

Mirae Asset Healthcare

Mirae Asset · Direct–Growth · rank #3 of 19 by Smart Score

Data updated

Trailing returns

vs Nifty 500 (index-fund proxy)
1 Year
28.1%
+27.4% vs index
3 Years
23.7%
+12.2% vs index
5 Years
17.8%
+7.7% vs index
Since launch
22.5%

Year-by-year performance

last entry = YTD
2021
+28.6%
2022
-10.5%
2023
+36.1%
2024
+41.2%
2025
-2.0%
2026
+28.9%

Why this score

Mirae Asset Healthcare scores 73/100 — #3 of 19 Pharma & Healthcare fund (Buy). It stands out for 3y return and 5y return — beating 79% of peers on 3y return. It has no major weak spot vs the category.

Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.

3Y return23.67% · 79th percentile in category
5Y return17.77% · 75th percentile in category
Expense ratio0.61% · 97th percentile in category
Sharpe ratio1.09 · 78th percentile in category
Sortino ratio1.71 · 80th percentile in category
1Y return28.14% · 85th percentile in category

Top holdings

top 5 = 38.9% of portfolio
1.Sun Pharmaceutical Industries Ltd10.32%
2.Divi's Laboratories Ltd9.97%
3.Torrent Pharmaceuticals Ltd6.41%
4.Laurus Labs Ltd6.37%
5.Apollo Hospitals Enterprise Ltd5.81%

28 disclosed equity positions · portfolio as of Oct 2026 · weights are % of total corpus.

Other Pharma & Healthcare funds